Abstract
There have been a lot of discussions concerning the relationship between testosterone serum levels in males and diabetes. Low testosterone is commonly associated with type 2 diabetes and metabolic syndrome. Testosterone therapy alters the body composition in a metabolically favorable manner. In this article we shed some light on the bidirectional relation between hypotestosteronemia and diabetes discussing also the possible mechanisms and the benefit of treatment.
Keywords: Hypotestosteronemia, testosterone, diabetes, glucose metabolism, metabolic syndrome, insulin resistance.
Current Diabetes Reviews
Title:Low Testosterone and Diabetes
Volume: 9 Issue: 5
Author(s): Khaled El Baba and Sami T. Azar
Affiliation:
Keywords: Hypotestosteronemia, testosterone, diabetes, glucose metabolism, metabolic syndrome, insulin resistance.
Abstract: There have been a lot of discussions concerning the relationship between testosterone serum levels in males and diabetes. Low testosterone is commonly associated with type 2 diabetes and metabolic syndrome. Testosterone therapy alters the body composition in a metabolically favorable manner. In this article we shed some light on the bidirectional relation between hypotestosteronemia and diabetes discussing also the possible mechanisms and the benefit of treatment.
Export Options
About this article
Cite this article as:
Baba El Khaled and Azar T. Sami, Low Testosterone and Diabetes, Current Diabetes Reviews 2013; 9 (5) . https://dx.doi.org/10.2174/15733998113099990071
DOI https://dx.doi.org/10.2174/15733998113099990071 |
Print ISSN 1573-3998 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6417 |
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Radiopharmaceutical Applications of Organometallic Technetium and Rhenium Complexes
Current Inorganic Chemistry (Discontinued) Beclin 1 Biology and its Role in Heart Disease
Current Cardiology Reviews Integrin αvβ3 as a Therapeutic Target for Blocking Tumor-Induced Angiogenesis
Current Drug Targets L-Proline Catalyzed Synthesis of Novel 5-{[2-(2-phenylpiperazin-1-yl)quinolin] methylene}-2,4-dione Derivatives
Letters in Organic Chemistry Histone and Non-Histone Targets of Dietary Deacetylase Inhibitors
Current Topics in Medicinal Chemistry Blending of Polyethylenimine with a Cationic Polyurethane Greatly Enhances Both DNA Delivery Efficacy and Reduces the Overall Cytotoxicity
Current Pharmaceutical Biotechnology Targeting Invasion Induction as a Therapeutic Strategy for the Treatment of Cancer
Current Cancer Drug Targets The Role of Glycogen Synthase Kinase-3β in Normal Haematopoiesis, Angiogenesis and Leukaemia
Current Medicinal Chemistry Meet Our Editorial Board Member
Current Pharmaceutical Biotechnology A Review on Novel Breast Cancer Therapies: Photodynamic Therapy and Plant Derived Agent Induced Cell Death Mechanisms
Anti-Cancer Agents in Medicinal Chemistry Exploration of Metastasis-related Proteins as Biomarkers and Therapeutic Targets in the Treatment of Head and Neck Cancer
Current Cancer Drug Targets Impact of microRNAs in Resistance to Chemotherapy and Novel Targeted Agents in Non-Small Cell Lung Cancer
Current Pharmaceutical Biotechnology An Update on Extemporaneous Preparation of Radiopharmaceuticals Using Freeze-Dried Cold Kits
Mini-Reviews in Medicinal Chemistry Multi-modal Anti-cancer Activities Provided by a Non-replicating Sendai Virus Envelope
Current Cancer Therapy Reviews Fluorescent Probes for the Detection of Hydrogen Peroxide in Biological Systems
Current Organic Chemistry Bortezomib as the First Proteasome Inhibitor Anticancer Drug: Current Status and Future Perspectives
Current Cancer Drug Targets Current Development of ROS-Modulating Agents as Novel Antitumor Therapy
Current Cancer Drug Targets Melatonin and Respiratory Diseases: A Review
Current Topics in Medicinal Chemistry Peptide-Receptor Ligands and Multivalent Approach
Anti-Cancer Agents in Medicinal Chemistry ROS-Responsive Nanomedicine: Towards Targeting the Breast Tumor Microenvironment
Current Medicinal Chemistry